Abstract
Dengue is a common vector-borne disease of tropical and subtropical areas, affecting about 50 million people each year and exposing more than 2.5 billion people at risk. Dengue virus (DENV), responsible for the disease, belongs to family Flaviviridae, genus Flavivirus and has four distinguished serotypes (DENV 1, DENV 2, DENV 3, and DENV 4). The main vector of the virus is Aedes aegypti mosquito. Water logging increases mosquito density and an increase in vector-borne diseases (such as dengue, malaria, West Nile fever) through the expansion in the number and range of vector habitats. Infection with any of the DENV serotypes may be asymptomatic in the majority of cases or may result in a wide spectrum of clinical symptoms, ranging from a mild flu-like syndrome (known as dengue fever [DF]) to the most severe forms of the disease; Dengue Hemorrhagic Fever/ Dengue Shock Syndrome (DHF/DSS). Recently in 2008, WHO has revised its classification and divides the clinical illness to non-severe dengue, dengue ± warning signs, and severe dengue. Pathogenesis of severe dengue disease is very complex and not properly elucidated. Timely diagnosis of the disease is the key to control it. Routine diagnosis largely depends upon NS1 antigen, IgM, and genome detection by different methods. Confirmatory diagnosis is by cell culture method, the most important of which is C6/36 mosquito cell line or intrathoracic inoculation of mosquito. Till date, no effective vaccine is available in the market. Different approaches are being used to develop various formulations of vaccine, but are of not much use. Alternative vaccine strategies in the form of small interfering RNA (siRNA) and micro RNA (miRNA) seem to be quite promising in present era. Though these technologies are in very primitive phase, various studies are going on all over the world to bring them to reality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal R, Kapoor S, Nagar R, Misra A, Tandon R, Mathur A et al (1999) Clinical study of the patients with dengue hemorrhagic fever during the epidemic of 1996 at Lucknow, India. SE Asian J Trop Med Public Health 30:735–740
Anonymous (1986) Dengue hemorrhagic fever, diagnosis, treatment and control. World health organization, Switzerland
Assenberg R, Mastrangelo E, Walter TS, Verma A, Milani M, Owens RJ et al (2009) Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication. J Virol 83(24):12895–12906
Bancroft TL (1906) On the aetiology of dengue fever. Aust Med Gaz 25:17–18
Barnes WJS, Rosen L (1974) Fatal hemorrhagic disease and shock associated with primary dengue infection on a pacific island. Am J Trop Med Hyg 23:495–506
Bhamarapravati N (1997) Live attenuated tetravalent dengue vaccine. In: Gubler DJ, Kuno G (eds) Dengue and dengue hemorrhagic fever. CAB International, London, pp 367–378
Bhamarapravati N, Yoksan S (1989) Study of bivalent dengue vaccine in volunteers. Lancet 1077
Bhamarapravati N, Yoksan S, Chayaniyayothian T, Angsubhakorn S, Bunyaratvej A (1987) Immunization with a live attenuated dengue-2 virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bull WHO 65:185–195
Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, Kabra SK, Broor S (2008) Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi. India Virol J 2008(5):1–4
Bhattacharjee N, Mukherjee KK, Chakravarti SK, Mukherjee MK, De PN, Sengupta M, Banik GB, Bhowmick P, Sinha SK, Chakraborty MS (1993) Dengue haemorrhagic fever (DHF) outbreak in Calcutta—1990. J Commun Dis 25:10–14
Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S et al (2009) Structure and functionality in flavivirus NS-proteins: prospectives for drug design. Antiviral Res
Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF, Bozza PT, Kubelka CF (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8:86
Brandt WE (1988) Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses. J Infect Dis 157:1105–1111
Brandt WE (1990) Development of dengue and Japanese encephalitis vaccines. J Infect Dis 162:577–583
Bray M, Lai C-J (1991) Construction of intertypic chimeric dengue viruses by substitution of structural protein genes. Proc Natl Acad Sci USA 88:10342–10346
Broor S, Dar L, Sengupta S, Chakaraborty M, Wali JP, Biswas A, Kabra SK, Jain Y, Seth P (1997) Recent dengue epidemic in Delhi, India. In: Saluzzo JE, Dodet B (ed) Factors in the emergence of arbovirus diseases, Elsevier, Paris, pp 123–127
Campbell CL, Black WCT, Hess AM, Foy BD (2008a) Comparative genomics of small RNA regulatory pathway components in vector mosquitoes. BMC Genomics 9(1):425
Campbell CL, Keene KM, Brackney DE, Olson KE, Blair CD, Wilusz J, Foy BD (2008b) Aedes aegypti uses RNA interference in defense against Sindbis virus infection. BMC Microbiol 8:47
Chambers TJ, Hahn CS, Galler R, Rice CM (1990) Flavivirus genome organization, expression and replication. Annul Rev Microbiol 44:649–688
Chambers TJ, Tsai TF, Pervikov Y, Monath TP (1997) Vaccine development against dengue and Japanese encephalitis: report of a world health organization meeting. Vaccine 15:1494–1502
Chen W, Kawano H, Men R, Clark D, Lai C-J (1995) Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. J Virol 69:5186–5190
Dar L, Broor S, Sengupta S, Xess I, Seth P (1999) The first major outbreak of dengue hemorrhagic fever in Delhi. India Emerg Infect Dis 5:589–590
Dar L, Gupta E, Narang P, Broor S (2006) Co-circulation of dengue serotypes 1,2,3 and 4 during the 2003 outbreak in Delhi. India Emerg Infect Dis 12:352–353
Dash PK, Saxena P, Abhyankar A, Bhargava R, Jana AM (2005) Emergence of dengue virus type-3 in northern India. SE Asian J Trop Med Public Health 36:370–377
Dash PK, Parida MM, Saxena P, Abhyankar A, Singh CP, Tewari KN, Jana AM, Sekhar K, Rao PV (2006) Reemergence of dengue virus type-3 (subtype-III) in India: implications for increased incidence of DHF & DSS. Virol J 6:3–55
de Macedo FC, Nicol AF, Cooper LD, Yearsley M, Pires AR, Nuovo GJ (2006) Histologic, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn Mol Pathol 15:223–228
Deubel V, Bordier M, Megret F, Gentry MK, Schlesinger JJ, Girard M (1991) Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology 180:442–447
Dietz V, Gubler DJ, Ortiz S, Kuno G, Casta-Velez A, Sather GE, Gomez I, Vergne E (1996) The 1986 dengue and dengue hemorrhagic fever epidemic in Puerto Rico: epidemiologic and clinical observations. PR Health Sci J 15:201–210
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669):806–811
Gaunt M, Sall A, de Lamballerie X et al (2001) Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol 82:1867–1876
Gubler DJ (1987) Dengue and dengue hemorrhagic fever in the Americas. PR Health Sci J 6:107–111
Gubler DJ (1989) Aedes aegypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up. Am J Trop Med Hyg 40:571–578
Gubler DJ (1997) Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G (eds) Dengue and dengue hemorrhagic fever. CAB International, London, pp 1–22
Gubler DJ (1998) The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med Singap 27:227–234
Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10:100–103
Gubler DJ (2006). Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 277, 3–16; discussion 16–22, 71–13, 251–253
Gubler DJ, editor KG (1997) Dengue and dengue hemorrhagic fever, CAB International, UK
Gubler DJ, Kuno G, Sather GE, Velez M, Oliver A (1984) Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 33:158–165
Gupta E, Dar L, Kapoor G, Broor S (2006) The changing epidemiology of dengue in Delhi. India Virol J 3:92
Guzman MG, Kouri G (2002) Dengue: an update. Lancet Infect Dis 2(1):33–42
Hahn YS, Galler R, Hunkapillar T, Dalrymple JM, Strauss JH, Strauss EG (1988) Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology 162:167–180
Halstead SB (1970) Observations related to pathogenesis of dengue hemorrhagic fever. VI. Hypotheses and discussion. Yale J Biol Med 42:350–362
Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481
Halstead SB, O’Rourke EJ (1977a) Antibody-enhanced dengue virus infection in primate leukocytes. Nature (London) 265:739–741
Halstead SB, O’Rourke EJ (1977b) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146:210–217
Hirsch A (1883) Dengue, a comparatively new disease: its symptoms. In: Handbook of geographical and historical pathology, vol 1. Sydenham Society, London, pp 55–81
Howe GM (1977) World geography of human diseases. Academic Press, Inc, New York
Kapoor M, Zhang L, Mohan PM, Padmanabhan R (1995) Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 162:175–180
Kochel T, Wu S-J, Raviprakash K, Hobart P, Hoffman SL, Hayes CG (1997) Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15:547–552
Kramer LD, Ebel GD (2003) Dynamics of flavivirus infection in mosquitoes. Adv Virus Res 60:187–232
Kuhn RJ, Zhang W, Rossmann MG, Pletnev SV, Corver J, Lenches E et al (2002) Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108(5):717–725
Kukreti H, Chaudhary A, Rautela RS, Anand R, Mittal V, Chhabra M, Bhattacharya D, Lal S, Rai A (2008) Emergence of an independent lineage of dengue virus type 1 (DENV-1) and its co-circulation with predominant DENV-3 during the 2006 dengue fever outbreak in Delhi. Int J Infect Dis 12(5):542–549
Kumar R, Tripathi S, Tambe JJ, Arora V, Nag VL (2008) Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. J Neurol Sci 269:41–48
Kurukumbi M, Wali JP, Broor S, Aggarwal P, Seth P, Handa R, Dhar L, Vajapayee M (2001) Seroepidemiology and active surveillance of dengue fever/dengue haemorrhagic fever in Delhi. Indian J Med Sci 55:149–156
Lanciotti RS et al (1994) Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 75(Pt 1):65–75
Leitmeyer KC (1999) Dengue virus structural differences that correlate with pathogenesis. J Virol 73(6):4738–4747
Limon-Flores AY, Perez-Tapia M, Estrada-Garcia I, Vaughan G, Escobar-Gutierrez A, Calderon-Amador J, Herrera-Rodriguez SE, Brizuela- Garcia A, Heras-Chavarria M, Flores-Langarica A, Cedillo-Barron L, Flores-Romo L (2005) Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int J Exp Pathol 86:323–334
Martina BEE, Koraka P, Osterhaus ADME (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22(4):564–581
Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL (1989) Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol 70:2037–2049
Mason PW, Pincus S, Fournier MJ, Mason TL, Shope RE, Paoletti E (1991) Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294–305
Messer WB (2003) Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9(7):800–809
Miller S, Kastner S, Krijnse-Locker J, Buhler S, Bartenschlager R (2007) The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2 K regulated manner. J Biol Chem 282(12):8873–8882
Netsawang J, Noisakran S, Puttikhunt C, Kasinrerk W, Wongwiwat W, Malasit P et al (2010) Nuclear localization of dengue virus capsid protein is required for DAXX interaction and apoptosis. Virus Res 147(2):275–283
Nobuchi H (1979) The symptoms of a dengue-like illness recorded in a Chinese medical encyclopedia. Kanpo Rinsho 26:422–425 (In Japanese)
Padbidri VS, Thakre JP, Risbud AR, Joshi GD, Singh A, Mavale MS, Gupta VP (1996) An outbreak of dengue hemorrhagic fever in Jammu. Indian J Virol 12:83–87
Pandey N, Nagar R, Gupta S, Omprakash, Khan D, Singh DD, Mishra G, Prakash S, Singh KP, Singh M, Jain A (2012) Trend of dengue virus infection at Lucknow, north India (2008–2010): a hospital based study. Indian J Med Res 136(5):862–867
Parida MM, Dash PK, Upadhyay C, Saxena P, Jana AM (2002) Serological and virological investigation of an outbreak of dengue fever in Gwalior, India. Indian J Med Res 116:248–254
Pepper OHP (1941) A note on David Bylon and dengue. Ann Med Hist 3rd Ser 3:363–368
Roehrig JT, Johnson AH, Hunt AR, Beaty BJ, Mathews JH (1992a) Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol 66:3385–3390
Roehrig JT, Mathews JH, Risi PA, Brubaker JR, Hunt AR (1992b) Mapping of biologically active helper T-cell epitopes on the flavivirus envelope glycoprotein. In: Brown F, Chanock RM, Ginsberg H, Lerner RA (eds) Vaccines 92. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 277–281
Rothman AL (2004) Dengue: defining protective versus pathologic immunity. J Clin Invest 113(7):946–951
Rush AB (1789) An account of the bilious remitting fever, as it appeared in Philadelphia in the summer and autumn of the year 1780. Medical enquiries and observations, Prichard and Hall, Philadelphia, pp 104–117
Sabin AB (1952) Research on dengue during World War II. Am J Trop Med Hyg 1:30–50
Sabin A (1959) Survey of knowledge and problems in field of arthropod-borne virus infections. Arch Gesamte Virusforsch 9:1–10
Sanchez-Vargas I, Scott JC, Poole-Smith BK, Franz AW, Barbosa-Solomieu V, Wilusz J, Olson KE, Blair CD (2009) Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito’s RNA interference pathway. PLoS Pathog 5(2):e1000299
WHO (2009) Dengue guidelines for diagnosis, treatment, prevention and control. World Health Organization, Geneva
Yap TL, Xu T, Chen YL, Malet H, Egloff MP, Canard B et al (2007) Crystal structure of the dengue virus RNA dependent RNA polymerase catalytic domain at 1.85 angstrom resolution. J Virol 81(9):4753–4765
Young PR, Hilditch PA, Bletchly C, Halloran W (2000) An antigen capture enzyme linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Micribiol 38(3):1053–1057
Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, Baker TS et al (2004) Conformational changes of the flavivirus E glycoprotein. Structure 12(9):1607–1618
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Jain, B., Jain, A. (2014). Dengue: A Water-Related Mosquito-Borne Disease. In: Singh, P., Sharma, V. (eds) Water and Health. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1029-0_1
Download citation
DOI: https://doi.org/10.1007/978-81-322-1029-0_1
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1028-3
Online ISBN: 978-81-322-1029-0
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)